Sleep Aids (Pharmacies) - Egypt

  • Egypt
  • Revenue in the Sleep Aids market is projected to reach US$3.29m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.03%, resulting in a market volume of US$3.82m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.03 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Egypt is experiencing significant growth due to changing customer preferences and local special circumstances.

Customer preferences:
Customers in Egypt are increasingly seeking sleep aids to address sleep disorders and improve their overall sleep quality. This trend is driven by several factors, including high levels of stress and anxiety, which can disrupt sleep patterns. Additionally, the prevalence of smartphones and other electronic devices has led to increased exposure to blue light, which can interfere with the body's natural sleep-wake cycle. As a result, consumers are turning to sleep aids to help them fall asleep faster and stay asleep longer.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Egypt is the growing demand for natural and herbal sleep aids. Consumers are becoming more conscious of the potential side effects of synthetic sleep aids and are seeking alternative options. Natural sleep aids, such as herbal supplements and aromatherapy products, are gaining popularity as they are perceived to be safer and have fewer side effects. This trend is also influenced by the global shift towards natural and holistic health remedies. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for sleep aids. This includes stocking a wider range of products, such as over-the-counter sleep aids, prescription medications, and natural remedies. Pharmacies are also providing additional services, such as sleep consultations and advice, to help customers find the most suitable sleep aid for their needs.

Local special circumstances:
Egypt has a high prevalence of sleep disorders, which is contributing to the growth of the Sleep Aids (Pharmacies) market. Factors such as a fast-paced lifestyle, work-related stress, and environmental factors, including noise pollution, can all contribute to sleep disturbances. As a result, there is a growing awareness and recognition of the importance of good sleep hygiene and the need for sleep aids to address sleep disorders.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in Egypt is also influenced by underlying macroeconomic factors. The country's growing middle class and increasing disposable income levels are enabling more consumers to afford sleep aids. Additionally, the expansion of the healthcare sector and increased access to healthcare services are driving the demand for sleep aids. The government's focus on improving healthcare infrastructure and increasing healthcare spending is further supporting the growth of the Sleep Aids (Pharmacies) market. In conclusion, the Sleep Aids (Pharmacies) market in Egypt is witnessing growth due to changing customer preferences, including the demand for natural sleep aids, and local special circumstances, such as the high prevalence of sleep disorders. The market is also influenced by underlying macroeconomic factors, such as the growing middle class and increased access to healthcare services. As the importance of sleep health continues to be recognized, the Sleep Aids (Pharmacies) market in Egypt is expected to continue its upward trajectory.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)